echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > "White Paper on Nutritional Diet for Chinese Cancer Patients (2020-2021)" released in Beijing

    "White Paper on Nutritional Diet for Chinese Cancer Patients (2020-2021)" released in Beijing

    • Last Update: 2020-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "Families, businesses, patient organizations and governments need to work together to promote scientific nutrition management, address malnutrition in patients, and improve the prevention, treatment and rehabilitation of tumors." Yang Yuanxin, Chairman of the Chinese Academy of Nutrition, stressed at the launch ceremony of the White Paper on Nutritional Diets for Cancer Patients in China (2020-2021).
    The White Paper, led by the Oncology Nutrition Management Branch of the Chinese Academy of Nutrition, jointly researched and published by Fessen Yuska Bihuari Pharmaceutical Co., Ltd. and the "Dancing with Cancer" public welfare organization, is the first white paper in China to focus on the nutritional diet of cancer patients, providing guidance and reference for the home-based nutritional diet of cancer patients.Professor Yu Kang published a white paper to investigate big data
    Professor Yu Kang, director of the clinical nutrition department of Beijing Concord Hospital, on behalf of the White Paper expert group published white paper survey data show that the incidence of severe malnutrition among patients with malignant tumors in China is as high as 58%, 45% of patients due to Surgical eating difficulties and reductions, with 86.57 per cent, 71.18 per cent and 64.82 per cent of patients with loss of appetite due to chemotherapy, targeted treatment and radiotherapy, nausea and vomiting, indigestion or constipation diarrhea, respectively. 30.04 percent of patients lost weight in the last three months, of which 51.39 percent lost more than 5 percent of their original body weight.
    White Paper proposes specific interventions and methods for the nutritional needs of specific tumors in different locations, stages of treatment and treatment. Professor Li Zengning, Vice Dean of the First Hospital affiliated with Hebei Medical University, and Director of the General Department of Oncology Hospital of the Chinese Academy of Medical Sciences, said: "The implementation of precision oncology nutrition must determine sensitive markers and detection methods for monitoring nutritional levels, accurate treatment options and nutritional interventions through accurate assessment of individual nutritional needs."
    Fessen Yuscabi China Executive Vice President and General Manager of Fakahuari, said: "The white paper is precisely the hope that there is a scientific authority, clear and understandable oncology nutrition 'treasure', for patients, family members and first-line clinical nutritionists to provide the basis and guidance for scientific nutrition management." "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.